Dana-Farber Cancer Institute at South Shore — Weymouth, Massachusetts

Dana-Farber Cancer Institute at South Shore is a clinical research site located in Weymouth, Massachusetts, United States 02190.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute at South Shore has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Early Stage Breast Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes.

Sponsors: Dana-Farber Cancer Institute.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Weymouth

Browse all research sites in Massachusetts · View every site in Weymouth

• DF/ BWCC in Clinical Affiliation with South Shore Hospital
• Dana-Farber/Brigham and Women's Cancer Center at South Shore Hospital
• South Shore Hospital Center for Wound Healing
• Dana-Farber Cancer Institute at South Shore Hospital
• Dana-Farber Brigham Cancer Center with South Shore Hospital
• South Shore Hospital
• Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital
• Dana-Farber at South Shore Hospital
• Boston Children's Hospital at Weymouth
• Coastal Research Associates
• Dana Farber Community Cancer Care-Weymouth
• Research Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute at South Shore?

Dana-Farber Cancer Institute at South Shore has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute at South Shore conducted?

Dana-Farber Cancer Institute at South Shore has 2 clinical trials on record, with 1 currently active. Their work covers Early Stage Breast Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes.

Is Dana-Farber Cancer Institute at South Shore accredited by Crixeo Clinical Trials?

Dana-Farber Cancer Institute at South Shore has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute at South Shore?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.